Anzeige
Meldung des Tages: Der nächste Lithium-Runner? EMP startet entscheidende Engineering-Phase

Becton Dickinson News

Aktie
WKN:  857675 ISIN:  US0758871091 US-Symbol:  BDX Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  USA
160,48 $
+0,85 $
+0,53%
140,31 € 17:48:14 Uhr
Depot/Watchlist
Marktkapitalisierung *
47,80 Mrd. €
Streubesitz
5,15%
KGV
31,83
Dividende
2,93 EUR
Dividendenrendite
2,23%
Nachhaltigkeits-Score
46 %
Index-Zuordnung
S&P 500
Weiter aufwärts? Long handeln - Jetzt mit Hebel 5,89: MM781H
Werbung

Becton Dickinson News

04.11.25 - PR Newswire
BD Achieves Milestone in AGILITY Study of Revello™ Vascular Covered Stent for Treatment of Peripheral Artery Disease
BD Achieves Milestone in AGILITY Study of Revello™ Vascular Covered Stent for Treatment of Peripheral Artery Disease PR Newswire
03.11.25 - PR Newswire
BD Receives FDA 510(k) Clearance and CE-IVDR Certification for High-Throughput Enteric Bacterial Panels on BD COR™ System
BD Receives FDA 510(k) Clearance and CE-IVDR Certification for High-​Throughput Enteric Bacterial Panels on BD COR™ System PR Newswire
22.10.25 - PR Newswire
BD Simplifies At-Home HPV Testing to Broaden Access to Cervical Cancer Screening Outside United States
BD Simplifies At-Home HPV Testing to Broaden Access to Cervical Cancer Screening Outside United States PR Newswire
16.10.25 - PR Newswire
BD Looks Ahead to the Next Era of Manufacturing Excellence in Broken Bow, NE and Celebrates 65 Years of Innovation in the Region
BD Looks Ahead to the Next Era of Manufacturing Excellence in Broken Bow, NE and Celebrates 65 Years of Innovation in the Region PR Newswire
15.10.25 - PR Newswire
BD Announces CFO Transition Plan
BD Announces CFO Transition Plan PR Newswire
09.10.25 - PR Newswire
BD to Announce Financial Results for its Fourth Quarter and Full Year of Fiscal 2025
BD to Announce Financial Results for its Fourth Quarter and Full Year of Fiscal 2025 PR Newswire
09.10.25 - PR Newswire
BD Reaches Major Milestone for Rotarex™ Catheter System with First Patient Enrolled in XTRACT™ Registry to Advance Real-World Evidence in Peripheral Artery Disease
BD Reaches Major Milestone for Rotarex™ Catheter System with First Patient Enrolled in XTRACT™ Registry to Advance Real-​World Evidence in Peripheral Artery Disease PR Newswire
08.10.25 - PR Newswire
BD and Opentrons Collaborate to Accelerate Single-Cell Multiomics Discoveries with Robotic Automation
BD and Opentrons Collaborate to Accelerate Single-​Cell Multiomics Discoveries with Robotic Automation PR Newswire
03.10.25 - PR Newswire
BD Celebrates 55 Years of Manufacturing Excellence and Impact in Sumter, S.C.
BD Celebrates 55 Years of Manufacturing Excellence and Impact in Sumter, S.C. PR Newswire
22.09.25 - PR Newswire
BD and Henry Ford Health Sign Pharmacy Automation Partnership to Revolutionize Medication Storage and Prescription Delivery
BD and Henry Ford Health Sign Pharmacy Automation Partnership to Revolutionize Medication Storage and Prescription Delivery PR Newswire
17.09.25 - PR Newswire
BD Marks 1,000th BD Rhapsody System, Driving Scientific Breakthroughs via Single-Cell Multiomics
BD Marks 1,000th BD Rhapsody System, Driving Scientific Breakthroughs via Single-​Cell Multiomics PR Newswire
02.09.25 - PR Newswire
BD Expands Peripheral Artery Disease Awareness Efforts with 'Love Your Limbs' Community Screening Initiative
BD Expands Peripheral Artery Disease Awareness Efforts with 'Love Your Limbs' Community Screening Initiative PR Newswire
14.08.25 - PR Newswire
BD to Present at Wells Fargo 2025 Healthcare Conference
BD to Present at Wells Fargo 2025 Healthcare Conference PR Newswire
07.08.25 - PR Newswire
BD Reports Third Quarter Fiscal 2025 Financial Results
BD Reports Third Quarter Fiscal 2025 Financial Results PR Newswire
05.08.25 - PR Newswire
BD Businesses Become First in MedTech to Achieve HIRC's Diamond Badge Across All Supply Chain Resiliency Categories
BD Businesses Become First in MedTech to Achieve HIRC's Diamond Badge Across All Supply Chain Resiliency Categories PR Newswire
04.08.25 - PR Newswire
BD to Invest $35 Million in Nebraska Facility to Expand Prefilled Flush Syringe Manufacturing to Support U.S. Health Care
BD to Invest $35 Million in Nebraska Facility to Expand Prefilled Flush Syringe Manufacturing to Support U.S. Health Care PR Newswire
31.07.25 - PR Newswire
BD Aims to Save Lives by Empowering Women with Choice and Access to Cervical Cancer Screening Self-Collected At Home
BD Aims to Save Lives by Empowering Women with Choice and Access to Cervical Cancer Screening Self-​Collected At Home PR Newswire
30.07.25 - PR Newswire
BD Receives FDA 510(k) Clearance for Rapid Point-of-Care COVID-19 Test
BD Receives FDA 510(k) Clearance for Rapid Point-​of-Care COVID-19 Test PR Newswire
23.07.25 - PR Newswire
BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs
BD Announces First Pharma-​Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs PR Newswire
15.07.25 - PR Newswire
Waters und der Geschäftsbereich Biosciences & Diagnostic Solutions von BD fusionieren und schaffen ein führendes Unternehmen für Biowissenschaften und Diagnostik, das sich auf regulierte, hochvolumige Tests konzentriert
Waters und der Geschäftsbereich Biosciences & Diagnostic Solutions von BD fusionieren und schaffen ein führendes Unternehmen für Biowissenschaften und Diagnostik, das ...

Newssuche

Videos

newspaper
10.03.26 -9,94%
Technical Trading: DAX Long Chance
DAX Long Typ: Turbo Open End WKN: VK2CGA Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »